Cabaletta Bio (CABA) Equity Average (2018 - 2025)

Cabaletta Bio has reported Equity Average for 8 years, with the latest figure at $125.8 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average fell 22.98% year-over-year to $125.8 million; the trailing twelve-month figure through Dec 2025 stood at $125.8 million (down 22.98% YoY), and the FY2025 full-year result was $132.2 million, down 31.95% from the prior year.
• Equity Average for Q4 2025 stood at $125.8 million, down from $159.0 million in the prior quarter.
• The five-year high for Equity Average was $229.0 million in Q1 2024, with the low at $90.7 million in Q3 2022.
• Average Equity Average over 5 years is $139.6 million, with a median of $129.3 million recorded in 2023.
• Year-over-year, Equity Average soared 133.43% in 2024 and plunged 40.19% in 2025.
• Tracing CABA's Equity Average over 5 years: stood at $117.3 million in 2021, then dropped by 18.83% to $95.2 million in 2022, then jumped by 108.58% to $198.6 million in 2023, then declined by 17.76% to $163.3 million in 2024, then fell by 22.98% to $125.8 million in 2025.
• The last three Equity Average figures came in at $125.8 million (Q4 2025), $159.0 million (Q3 2025), and $150.0 million (Q2 2025), per Business Quant data.

Peer Comparison